Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CONMED CorpCNMD · Entity 4691 | Director | May 31, 2024 | June 05, 2024 |
| Forest City Realty Trust, Inc.FCEA · Entity 161862 | Director | April 16, 2018 | April 25, 2018 |
| ITRON, INC.ITRI · Entity 2773 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CONMED Corp
Report date May 31, 2024 · Filed June 05, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,856 |
Reported balance
After 2024-05-31 transaction · row 1
1 source rowRow 1 · 2024-05-31 · Exercise / conversion · Acquired 302 · Balance 3,856 |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2033-06-01 | Direct | 0 |
Reported balance
After 2024-05-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-05-31 · Exercise / conversion · Disposed 302 · Balance 0 F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period. |
| Common StockSEC Table I · non-derivative | IndirectCoppersmith Capital Management, LLC | 0 |
Reported balance
Holding disclosure · report date 2024-05-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 0 F1: Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Mr. Lande, as a Managing Member of Coppersmith Capital Management, LLC ("Coppersmith Capital"), may be deemed the beneficial owner of the 1,630,800 shares of Common Stock, $0.01 par value ("Common Stock") beneficially owned by Coppersmith Capital, the Investment Adviser to a number of investment funds or managed accounts. Mr. Lande disclaims beneficial ownership of such Common Stock except to the extent of his pecuniary interest therein.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
Forest City Realty Trust, Inc.
Report date April 16, 2018 · Filed April 25, 2018
This filing explicitly reported no securities owned.
ITRON, INC.
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 11,373 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 608 · Balance 11,373 F1: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of common stock independent members of Itron's board of directors receive quarterly as part of their annual compensation for board service.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2019 Filed Jun 4, 2019 21:07 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 2,165 | $0.00 Strike: $79.94 | $0.00 |
DisclosureSEC source: 0001127602-19-020750 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,165 Underlying: Common Stock · 2,165 shares Expires 2029-06-03 F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and otherwise would have vested 100% after a one year period. Read SEC document |
| June 03, 2019 Filed Jun 4, 2019 21:07 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,407 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020750 · form4.xml · derivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407 Underlying: Common Stock · 1,407 shares Expires 2029-06-03 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:50 UTC | CONMED Corp CNMD · Entity 4691 | Disposition to issuerRsus (restricted Stock Units) · Derivative | 2,739 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-063962 · form4.xml · derivative · entry 3 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,739 shares Expires 2026-06-01 F1 · kind: At Mr. Lande's request, the Board cancelled his 2016 RSUs and Stock Options. Mr. Lande received no value for the cancellation of these RSUs and Stock Options. F3 · derivative.exercise_date: Each restricted stock unit ("RSU") represented a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and were subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs otherwise generally vesting 100% after a one year period. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 18:50 UTC | CONMED Corp CNMD · Entity 4691 | Disposition to issuerOptions To Purchase Common Stock · Derivative | 5,396 | $41.06 Strike: $41.06 | $221,559.76 |
DisclosureSEC source: 0001127602-16-063962 · form4.xml · derivative · entry 2 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,396 shares Expires 2026-06-01 F1 · kind: At Mr. Lande's request, the Board cancelled his 2016 RSUs and Stock Options. Mr. Lande received no value for the cancellation of these RSUs and Stock Options. F2 · derivative.exercise_date: The incentive stock options ("ISOs") were granted under the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan and otherwise would have vested 100% after a one year period. Read SEC document |
| September 13, 2016 Filed Sep 15, 2016 14:16 UTC | ITRON, INC. ITRI · Entity 2773 | OtherCommon Stock | 6,790 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-16-005691 · form409158005_09152016.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,235 F1 · kind: Represents shares acquired by Mr. Lande in connection with a pro rata distribution from Coppersmith Capital Partners, LLC to its members. Mr. Lande has exclusive voting and investment power over the acquired shares reported on this Form 4 and has 100% of the pecuniary interest in such shares. Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 22:59 UTC | ITRON, INC. ITRI · Entity 2773 | GrantCommon Stock | 463 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-062151 · form4.xml · nonDerivative · entry 1 Lande Jerome J. · CIK 0001578266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,908 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.